Stay updated with breaking news from Agrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Agile Therapeutics (NASDAQ:AGRX – Get Free Report) was upgraded by Maxim Group from a “hold” rating to a “buy” rating in a report released on Friday, FlyOnTheWall reports. Other equities research analysts have also issued research reports about the company. StockNews.com started coverage on Agile Therapeutics in a research note on Thursday, August 17th. They […]
HC Wainwright reaffirmed their buy rating on shares of Agile Therapeutics (NASDAQ:AGRX – Get Rating) in a research note released on Wednesday morning, Stock Target Advisor reports. The firm currently has a $12.00 target price on the specialty pharmaceutical company’s stock. HC Wainwright also issued estimates for Agile Therapeutics’ Q2 2023 earnings at ($3.45) EPS, […]
Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Rating) – Stock analysts at HC Wainwright issued their FY2023 earnings per share estimates for Agile Therapeutics in a research report issued to clients and investors on Wednesday, June 7th. HC Wainwright analyst O. Livnat anticipates that the specialty pharmaceutical company will post earnings per share of ($6.05) for […]
StockNews.com lowered shares of Agile Therapeutics (NASDAQ:AGRX – Get Rating) from a hold rating to a sell rating in a research note published on Thursday. Agile Therapeutics Price Performance AGRX stock opened at $6.45 on Thursday. The firm has a fifty day moving average price of $2.15 and a two-hundred day moving average price of […]
Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Rating) was the target of a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 33,800 shares, an increase of 350.7% from the March 31st total of 7,500 shares. Currently, 3.8% of the company’s stock are short sold. Based […]